05:49 PM EDT, 09/03/2024 (MT Newswires) -- Joseph P Lyssikatos, Chief Scientific Officer, on August 29, 2024, sold 12,000 shares in Enliven Therapeutics ( ELVN ) for $269,841. Following the Form 4 filing with the SEC, Lyssikatos has control over a total of 1,077,936 shares of the company, with 1,077,936 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1672619/000141588924022704/xslF345X05/form4-09032024_090954.xml